INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Brain & Mood desk →

1,209 studies · page 49 of 51

2006 / Randomized controlled trial

Iron or zinc supplements did not improve cognitive performance in lead-exposed Mexican schoolchildren.

In a randomized, double-blind trial, 602 schoolchildren aged 6 to 8 years received daily iron (30 mg), zinc (30 mg), both, or placebo for 6 months. Among the 527 participants completing treatment, testing evaluated 11 cognitive domains across memory, attention, learning, and visual-spatial abilities. Supplementation produced no consistent or durable differences in cognitive performance either immediately after treatment or after an additional 6 months of follow-up.

Rico JA, Kordas K, López P, et al. Pediatrics, 2006. PMID 16510631

2006 / Randomized crossover trial

A gluten-free, casein-free diet showed no significant benefit for children with autism.

A preliminary randomized, double-blind crossover trial examined the effects of a gluten-free and casein-free diet over 12 weeks in 15 children aged 2-16 years with autism spectrum disorder. Group-level analyses of autistic symptoms and urinary peptide concentrations revealed no statistically significant outcomes. While several parents reported behavioral improvements in their children, objective testing did not confirm diet efficacy.

Elder JH, Shankar M, Shuster J, et al. J Autism Dev Disord, 2006. PMID 16555138

2006 / Randomized controlled trial

Flavanol-rich cocoa increased BOLD fMRI signal intensity during a cognitive task in healthy young subjects.

Functional magnetic resonance imaging (fMRI) was used to measure blood oxygenation level-dependent (BOLD) responses to a cognitive task in 16 healthy young participants after consuming flavanol-rich cocoa (5 days of 150 mg cocoa flavanols). Ingestion of the flavanol-rich cocoa led to an increase in BOLD signal intensity during the task, though no significant effects were seen on behavioral reaction times, switch cost, or heart rate. Additionally, a pilot study demonstrated that a single acute dose of 450 mg flavanols increased cerebral blood flow to gray matter.

Francis ST, Head K, Morris PG, et al. J Cardiovasc Pharmacol, 2006. PMID 16794461

2006 / Experimental controlled trial

Orange lens blue blocker glasses impeded bright light-induced melatonin suppression compared with grey lenses in a 14-subject study.

Fourteen normal subjects were exposed to a 60-minute nocturnal bright light pulse (1300 lx behind filters) while wearing orange lens blue blocker glasses or grey lens glasses. With the grey lenses, a significant 46% reduction in salivary melatonin was observed (95% CI, 35-57%; P < 0.05), whereas a non-significant increase of 6% occurred with the orange lenses (95% CI, -20% to 9%). The authors concluded that blue blockers represent an elegant means to prevent light-induced melatonin suppression, but further studies are needed to show that these glasses could facilitate adaptation to night work.

Sasseville A, Paquet N, Sévigny J, et al. J Pineal Res, 2006. PMID 16842544

2006 / Interventional PET imaging study

Cigarette smoking in amounts used by typical daily smokers leads to nearly complete occupancy of brain alpha 4 beta 2* nicotinic acetylcholine receptors.

Eleven tobacco-dependent smokers participated in 14 2-FA PET scanning sessions during which they smoked 1 of 5 assigned amounts (none, 1 puff, 3 puffs, 1 full cigarette, or to satiety [2 1/2 to 3 cigarettes]). Smoking 0.13 (1 to 2 puffs) of a cigarette resulted in 50% occupancy of alpha 4 beta 2* nAChRs for 3.1 hours, and a venous plasma nicotine concentration of 0.87 ng/mL was associated with 50% occupancy. Smoking a full cigarette or more resulted in more than 88% receptor occupancy and was accompanied by a reduction in cigarette craving.

Brody AL, Mandelkern MA, London ED, et al. Arch Gen Psychiatry, 2006. PMID 16894067

2006 / Randomised double-blind placebo-controlled trial

Zinc supplementation showed mixed effects on cognitive measures at 3 months, with no consistent overall cognitive benefit in healthy older adults.

A randomized, double-blind, placebo-controlled trial evaluated the effects of 0 (placebo), 15, or 30 mg/day of zinc supplementation over 3 and 6 months in 387 healthy adults aged 55-87 years. Younger adults (<70 years) outperformed older adults (>70 years) on all tests. For two out of eight dependent variables, significant interactions were observed: both 15 and 30 mg/day showed a beneficial effect at 3 months only on one measure of spatial working memory, whereas 15 mg/day showed a detrimental effect on one measure of attention. The authors note that further research is needed to determine whether findings apply to older adults in poorer health or with less adequate zinc status.

Maylor EA, Simpson EE, Secker DL, et al. Br J Nutr, 2006. PMID 17010236

2006 / Randomized controlled trial

In patients with chronic tension-type headache, relaxation training increased headache-free periods and days directly post-treatment compared to acupuncture.

Ninety consecutive patients with chronic tension-type headache were randomized to receive acupuncture, relaxation training, or physical training. Headache intensity, headache-free days, and headache-free periods were assessed via visual analogue scale and headache diary at 4 weeks before, immediately after, and at 3 and 6 months post-treatment. Immediately after treatment, the number of headache-free periods and days was significantly higher in the relaxation group compared with the acupuncture group. No other significant differences between groups were observed at any time point.

Söderberg E, Carlsson J, Stener-Victorin E Cephalalgia, 2006. PMID 17059439

2006 / Randomized, double-blind, placebo-controlled trial

Long-term vitamin E supplementation did not provide cognitive benefits among generally healthy older women.

In a substudy of the Women's Health Study, 6,377 women aged 65 or older were randomly assigned to receive 600 IU of vitamin E (alpha-tocopherol acetate) on alternate days or placebo. Cognitive assessments were conducted every 2 years by telephone over up to 9.6 years of treatment. No differences in global cognitive score were found between the vitamin E and placebo groups at the first assessment (mean difference, -0.01; 95% CI, -0.04 to 0.03) or at the final assessment (mean difference, 0.00; 95% CI, -0.04 to 0.04). Cognitive change over time was similar between groups (mean difference in change, 0.02; 95% CI, -0.01 to 0.05; P = .16), and the relative risk of substantial cognitive decline was 0.92 (95% CI, 0.77 to 1.10).

Kang JH, Cook N, Manson J, et al. Arch Intern Med, 2006. PMID 17159011

2005 / fMRI intervention study

Glucose ingestion dose-dependently reduced hypothalamic fMRI signal in normal-weight men.

Using fMRI, researchers measured hypothalamic neuronal activity in 15 normal-weight men after an overnight fast. Participants were scanned for 37 minutes and ingested either water or a glucose solution (25 or 75 g) after 7 minutes. Glucose ingestion produced a prolonged decrease in the hypothalamic fMRI signal that started shortly after drinking began and lasted at least 30 minutes. This response was dose-dependent, with a larger glucose load causing a larger signal decrease, which was most pronounced in the upper anterior hypothalamus.

Smeets PA, de Graaf C, Stafleu A, et al. Neuroimage, 2005. PMID 15627579

2005 / Randomized controlled trial

Saffron extract showed similar efficacy to fluoxetine for mild to moderate depression

In a 6-week trial of 40 adults with mild to moderate depression, saffron extract (30 mg daily) was found to be similarly effective compared to fluoxetine (20 mg daily; F = 0.13, d.f. = 1, P = 0.71). No significant differences between groups were observed regarding side effects. The authors concluded that Crocus sativus is efficacious for depression, though larger trials remain necessary.

Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, et al. J Ethnopharmacol, 2005. PMID 15707766

2005 / Double-blind randomized controlled trial

Daily vitamin E supplementation did not reduce the risk of progression from mild cognitive impairment to Alzheimer's disease over three years.

In a double-blind trial, 769 subjects with amnestic mild cognitive impairment were randomly assigned to receive 2000 IU of vitamin E daily, 10 mg of donepezil daily, or placebo for three years. Over three years, possible or probable Alzheimer's disease developed in 212 subjects. Compared to placebo, there were no significant differences in progression to Alzheimer's disease in the vitamin E group (hazard ratio, 1.02; 95% CI, 0.74 to 1.41; P=0.91) or the donepezil group (hazard ratio, 0.80; 95% CI, 0.57 to 1.13; P=0.42). Donepezil reduced progression likelihood during the first 12 months (P=0.04), but vitamin E showed no benefit at any point, including among apolipoprotein E epsilon4 carriers.

Petersen RC, Thomas RG, Grundman M, et al. N Engl J Med, 2005. PMID 15829527

2005 / Randomized controlled trial

Iron and zinc supplementation does not consistently improve behavior in lead-exposed children

In a 6-month randomized trial, 602 first-grade Mexican children with lead exposure received daily 30 mg ferrous fumarate, 30 mg zinc oxide, both nutrients, or a placebo. Baseline blood lead averaged 11.5 mug/dL. The interventions did not show treatment effects on average score changes for parent- or teacher-assessed behaviors. However, children given zinc were more likely to resolve clinically significant oppositional ratings from teachers. Overall, the supplementation did not consistently improve behavior.

Kordas K, Stoltzfus RJ, López P, et al. J Pediatr, 2005. PMID 16291354

2005 / Double-blind randomized comparative trial

Formula with DHA and arachidonic acid showed possible neurodevelopmental benefits in larger preterm infants.

In a double-blind randomized comparative study, 27 preterm infants received formula with (n=16) or without (n=11) arachidonic acid (AA) and docosahexaenoic acid (DHA) for 6 months. Mean Mental Development Index scores for supplemented versus non-supplemented groups were 96.1 +/- 8.6 vs 91.7 +/- 10.4 at 6 months and 98.7 +/- 8.0 vs 90.5 +/- 6.9 at 1 year (p = 0.020). Mean Physical Development Index scores were 102.2 +/- 10.5 vs 95.4 +/- 13.2 at 6 months and 98.0 +/- 5.8 vs 86.7 +/- 11.1 at 1 year (p = 0.008). No differences were found in visual acuity, physical examination variables, or vital signs, and no obvious adverse effects occurred.

Fang PC, Kuo HK, Huang CB, et al. Chang Gung Med J, 2005. PMID 16382755

2004 / Randomized, placebo-controlled, matched-pairs, double-blind trial

Oral NADH supplementation for 6 months prevented cognitive decline and improved total MDRS scores in patients with Alzheimer's disease.

A 6-month randomized, double-blind, matched-pairs trial evaluated 10 mg/day of stabilized oral NADH versus placebo in 26 patients with probable Alzheimer's disease. After 6 months, patients taking NADH showed no evidence of progressive cognitive deterioration and achieved significantly higher total scores on the MDRS compared with placebo (p < 0.05). Subscale analysis showed significantly better performance with NADH in verbal fluency (p = 0.019) and visual-constructional ability (p = 0.038), with a trend in abstract verbal reasoning (p = 0.08). No differences were found between groups for attention, memory, or Clinical Dementia Rating scores.

Demarin V, Podobnik SS, Storga-Tomic D, et al. Drugs Exp Clin Res, 2004. PMID 15134388

2004 / Double-blind, placebo-controlled crossover trial

Artificial food colourings and sodium benzoate increased parent-reported hyperactive behaviour in 3-year-old children.

Following a one-week elimination diet, 277 3-year-old children completed a three-week double-blind crossover study receiving either a placebo mixture or an active drink with artificial colourings (20 mg daily) and sodium benzoate (45 mg daily). Significant reductions in hyperactive behaviour occurred during the withdrawal phase. Based on parental reports, hyperactive behaviour increased significantly more during the active period compared to placebo, regardless of baseline hyperactivity or atopy status. No significant differences were observed on objective clinic testing.

Bateman B, Warner JO, Hutchinson E, et al. Arch Dis Child, 2004. PMID 15155391

2004 / Randomized controlled trial

Daily antioxidant, zinc, and copper supplementation showed no beneficial or harmful effect on cognition in older adults after nearly seven years.

Participants in the Age-Related Eye Disease Study were randomly assigned to receive daily antioxidants (500 mg vitamin C, 400 IU vitamin E, 15 mg beta carotene), zinc and copper (80 mg zinc, 2 mg cupric oxide), both, or placebo. A cognitive battery was administered to 2,166 elderly individuals after a median of 6.9 years of treatment. Treatment groups did not differ on any of the six cognitive tests (p > 0.05 for all), showing neither benefit nor harm on cognition.

Yaffe K, Clemons TE, McBee WL, et al. Neurology, 2004. PMID 15534261

2004 / Randomized, controlled, double-blind crossover trial

In patients with Parkinson's disease, 30 g of Mucuna pruriens seed powder showed faster onset and longer on-time compared to standard levodopa/carbidopa.

Eight Parkinson's disease patients completed a randomized, double-blind crossover trial challenging them with single doses of 200/50 mg L-dopa/carbidopa (LD/CD) and 15 g and 30 g of Mucuna pruriens preparation at weekly intervals. Compared with standard LD/CD, the 30 g mucuna dose led to a significantly faster onset of effect (34.6 vs 68.5 min; p = 0.021) and a 21.9% (37 min) longer mean on-time (p = 0.021). Peak L-dopa plasma concentrations were 110% higher and the area under the curve was 165.3% larger (p = 0.012) with 30 g mucuna. No significant differences were observed in dyskinesias or tolerability.

Katzenschlager R, Evans A, Manson A, et al. J Neurol Neurosurg Psychiatry, 2004. PMID 15548480

2003 / Randomized controlled dose-response trial

Restricting sleep to 4 or 6 hours per night for 14 days causes cumulative, dose-dependent cognitive deficits comparable to total sleep deprivation.

Healthy adults were randomized to 8 h, 6 h, or 4 h time in bed per night for 14 consecutive days, or subjected to 3 nights of total sleep deprivation (0 h). Chronic sleep restriction to 4 h or 6 h per night led to significant cumulative, dose-dependent deficits in cognitive performance across all tasks, equivalent to up to 2 nights of total sleep deprivation. Subjective sleepiness ratings increased acutely but showed only small further increases, with subjects largely unaware of their escalating deficits. Across conditions, lapses in behavioral alertness were near-linearly related to cumulative wakefulness exceeding 15.84 h (s.e. 0.73 h).

Van Dongen HP, Maislin G, Mullington JM, et al. Sleep, 2003. PMID 12683469

2003 / Crossover feeding trial

Varying dietary manganese from 0.8 to 20 mg/d for 8 weeks did not alter neurological measures in healthy young women.

Healthy young women were fed diets containing 0.8 or 20 mg/d of manganese for 8 weeks each in a crossover design, with fat provided as either cocoa butter or corn oil. When consuming the low-manganese diet compared with the high-manganese diet, subjects absorbed a significantly higher percentage of (54)Mn but had a significantly longer biological half-life of absorbed (54)Mn. Manganese intake did not affect neurological measures and only minimally affected psychological variables, suggesting efficient homeostatic maintenance across these intake levels.

Finley JW, Penland JG, Pettit RE, et al. J Nutr, 2003. PMID 12949376

2002 / Randomized controlled trial

Gluten- and casein-free diet improved development in children with autistic syndromes.

Twenty children with autistic syndromes and urinary peptide abnormalities were split into a diet group or an untreated control group of 10 children each. After one year of follow-up, children consuming the gluten- and casein-free diet demonstrated significantly better development compared to the control group.

Knivsberg AM, Reichelt KL, Høien T, et al. Nutr Neurosci, 2002. PMID 12168688

2002 / Randomized controlled trial

High-dose ascorbic acid increases intercourse frequency and improves depressive symptoms in healthy adults

In a randomized double-blind, placebo-controlled 14-day trial, 81 healthy young adults took either 3,000 mg daily of sustained-release ascorbic acid or a placebo. Participants with partners logged sexual activity in diaries and completed depression inventories. Ascorbic acid increased penile-vaginal intercourse frequency, particularly in women and couples living apart, while also lowering Beck Depression scores compared to placebo.

Brody S Biol Psychiatry, 2002. PMID 12208645

2002 / Randomized controlled trial

A confectionery snack improved sustained attention in young boys following a fast

A randomized trial tested cognitive performance after an overnight fast in 21 boys aged 9 to 12 years receiving a confectionery snack or a noncalorie snack. Ingestion of the confectionery snack significantly improved vigilance attention performance, showing higher hit rates and lower miss rates. False alarm rates declined with the confectionery snack over time. However, no significant differences appeared in tests of verbal memory, spatial memory, visual perception, or digit span.

Busch CR, Taylor HA, Kanarek RB, et al. Physiol Behav, 2002. PMID 12419410

2002 / Laboratory experiment (2x2x2 factorial design)

Cognitive distraction led to higher food intake overall and triggered greater overeating in restrained eaters consuming perceived high-calorie food.

An experiment with a 2 (restrained/unrestrained) x 2 (distraction yes/no) x 2 (perceived calories high/low) design evaluated ice-cream consumption in a taste test setting. A significant interaction was found: in the high-calorie condition, restrained eaters ate the same amount as unrestrained eaters when not distracted, but considerably more when distracted. Additionally, an unexpected main effect showed that both restrained and unrestrained eaters consumed more ice cream when distracted than when not distracted.

Boon B, Stroebe W, Schut H, et al. Br J Health Psychol, 2002. PMID 14596713

2001 / Randomized controlled trial

Adding arachidonic and docosahexaenoic acids to infant formula did not enhance term infant development.

A double-blind randomized trial assigned 239 term infants to receive formula with or without arachidonic acid and docosahexaenoic acid for 1 year, alongside 165 breastfed reference infants. While supplemented formulas increased plasma and red blood cell fatty acid levels to match breastfed infants, no developmental test results differed among groups from birth to 14 months. Measures of growth, visual acuity, information processing, language, and temperament showed no benefits.

Auestad N, Halter R, Hall RT, et al. Pediatrics, 2001. PMID 11483802